Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04336280
Other study ID # IUC - Detrusor Underactiivity
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 20, 2020
Est. completion date March 25, 2020

Study information

Verified date April 2020
Source Mutah University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Detrusor underactivity (DU) is a known disease of the muscles of the urinary bladder that defined as a weak contraction of the muscle resulting in a failure to achieve complete bladder emptying. Recently, DU as a cause of Lower Urinary Tract Symptoms in both men and women has been increasingly gaining attention. There is a major issue in differentiation of underactive bladder symptoms and other causes of lower urinary tract symptoms such as detrusor hyperactivity and impaired contractility (DHIC), hypersensitive bladder (HSB), detrusor overactivity (DO), bladder outlet obstruction (BOO) and Dysfunctional Voiding (DV). Urodynamics (UDS) is the standard diagnostic tool, it includes invasive recording of the pressure that is produced when the bladder muscle contracts via pressure sensors introduced in the urinary bladder through special types of urethral catheters. This study aims to determine the prevalence of DU along with its symptomatic and urodynamics (UDS) characteristics of DU in Jordanian population through a retrospective chart review.


Recruitment information / eligibility

Status Completed
Enrollment 206
Est. completion date March 25, 2020
Est. primary completion date February 28, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years to 87 Years
Eligibility Inclusion Criteria:

- Patients underwent UDS from July 2016 to August 2019

Exclusion Criteria:

- Patients with neurogenic bladder (NB) due to known underlying neurological disease, history of open pelvic surgery or major abdominal surgery, or using indwelling catheters or clean intermittent catheterization (CIC).

Study Design


Intervention

Other:
Symptom questionnaire
Arabic version of the International Prostate Symptom Score: Known and validated questionnaire to quantify and qualify the severity of symptoms of the lower urinary tract
Diagnostic Test:
Urodynamics
Urodynamics: the standard diagnostic tool, it includes invasive recording of the pressure that is produced when the bladder muscle contracts via pressure sensors introduced in the urinary bladder through special types of urethral catheters.

Locations

Country Name City State
Jordan Istishari Urology Center (IUC) Amman

Sponsors (2)

Lead Sponsor Collaborator
Mutah University Istishari Urology Center

Country where clinical trial is conducted

Jordan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of detrusor underactivity in Jordan The proportion of patients with lower urinary tract symptoms found to be affected by Detrusor underactivity 3 years
Primary Symptomatic presentation of Detrusor underactivity Arabic version of the International Prostate Symptom Score was used to assess the prevalence and severity of the symptoms that are associated with detrusor underactivity. The questionnaire includes 8 questions, the 1st 7 questions are about the urinary symptoms (Incomplete emptying, urinary frequency, intermittency, urgency, weak urine stream, straining and nocturia) and the 8th is about Quality of Life due to Urinary Symptoms. Each question concerning urinary symptoms allows the patient to choose one out of six answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic). The answers to the 8th question (quality of life) range from "delighted" to "terrible" or 0 to 6. over one month period prior to clinical evaluation during the 3 years time period
Primary Urodynamics parameters Urodynamics is a series of tests conducted in an outpatient setting that evaluates the function of the urinary bladder, including physiological parameters of how completely the bladder, sphincter and urethra are storing and releasing urine. These parameters are recorded by pressure sensors that are inserted into the bladder via special urinary catheters to measure the pressure that is generated during storing and releasing urine. The assessment of urodynamic variables is based on bladder capacity, presence of involuntary bladder muscle contractions, bladder volume at 1st sensation of bladder filling, bladder volumes at normal and strong desire for urination, detrusor pressure at maximum flow of urine during voiding, volume voided, and the post-void residual urine volume. All urodynamic testing was performed based on the International Continence Society standards. Each test takes around 30-45 minutes, all urodymanics studies were performed during the study period
See also
  Status Clinical Trial Phase
Completed NCT04161183 - Extracoporeal Shock Wave Therapy (ESWT) for the Treatment of Detrusor Underactivity/ Underactive Bladder (DU/UAB) N/A
Completed NCT04543552 - A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
Completed NCT05359484 - Delta Q Value to Discriminate Detrusor Underactivity From Bladder Outlet Obstruction Phase 2/Phase 3
Completed NCT00441428 - Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity Phase 2
Completed NCT05470751 - GentleCathâ„¢ for Men Intermittent Catheter With FeelCleanâ„¢ Technology
Completed NCT04981080 - DU and BOO in Women With and Without Symptoms of VD
Recruiting NCT06020963 - Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding Efficiency N/A
Completed NCT03175029 - Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. Phase 2
Active, not recruiting NCT02193451 - Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods N/A